GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Adlai Nortye Ltd (NAS:ANL) » Definitions » Pretax Margin %

ANL (Adlai Nortye) Pretax Margin % : % (As of Jun. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Adlai Nortye Pretax Margin %?

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Adlai Nortye's Pre-Tax Income for the three months ended in Jun. 2024 was $0.00 Mil. Adlai Nortye's Revenue for the three months ended in Jun. 2024 was $0.00 Mil. Therefore, Adlai Nortye's pretax margin for the quarter that ended in Jun. 2024 was %.

The historical rank and industry rank for Adlai Nortye's Pretax Margin % or its related term are showing as below:


ANL's Pretax Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -136.82
* Ranked among companies with meaningful Pretax Margin % only.

Adlai Nortye Pretax Margin % Historical Data

The historical data trend for Adlai Nortye's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Adlai Nortye Pretax Margin % Chart

Adlai Nortye Annual Data
Trend Dec21 Dec22 Dec23
Pretax Margin %
-123.95 - -2,084.56

Adlai Nortye Quarterly Data
Dec21 Mar22 Jun22 Dec22 Mar23 Jun23 Dec23 Jun24
Pretax Margin % Get a 7-Day Free Trial - - - - -

Competitive Comparison of Adlai Nortye's Pretax Margin %

For the Biotechnology subindustry, Adlai Nortye's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Adlai Nortye's Pretax Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Adlai Nortye's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where Adlai Nortye's Pretax Margin % falls into.


;
;

Adlai Nortye Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

Adlai Nortye's Pretax Margin for the fiscal year that ended in Dec. 2023 is calculated as

Pretax Margin=Pre-Tax Income (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=-104.228/5
=-2,084.56 %

Adlai Nortye's Pretax Margin for the quarter that ended in Jun. 2024 is calculated as

Pretax Margin=Pre-Tax Income (Q: Jun. 2024 )/Revenue (Q: Jun. 2024 )
=0/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Adlai Nortye  (NAS:ANL) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.

Adlai Nortye Pretax Margin % Related Terms

Thank you for viewing the detailed overview of Adlai Nortye's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Adlai Nortye Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Adlai Nortye Ltd (NAS:ANL) » Definitions » Pretax Margin %
Comparable Companies
ABOS IVVD CLSD MNOV AVTE ACRV NTRB EPIX IGMS DOMH VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
N/A
Address
685 US Highway 1, New Jersey Biotechnology Development Center, 2nd floor, North Brunswick, NJ, USA, 08902
Website
https://www.adlainortye.com
Adlai Nortye Ltd is a clinical-stage biotechnology company focused on the discovery and development of cancer therapies for patients across the spectrum of tumor types. The company has a robust pipeline of drug candidates which includes buparlisib (AN2025), palupiprant (AN0025), and AN4005 in the clinical stage, and AN8025, AN9025, and AN1025 in the preclinical stage.